PortfoliosLab logo
ELMD vs. BSX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ELMD and BSX is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

ELMD vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Electromed, Inc. (ELMD) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

ELMD:

0.51

BSX:

1.91

Sortino Ratio

ELMD:

1.06

BSX:

2.47

Omega Ratio

ELMD:

1.14

BSX:

1.40

Calmar Ratio

ELMD:

0.61

BSX:

2.85

Martin Ratio

ELMD:

1.52

BSX:

11.63

Ulcer Index

ELMD:

18.27%

BSX:

3.81%

Daily Std Dev

ELMD:

51.77%

BSX:

22.26%

Max Drawdown

ELMD:

-78.65%

BSX:

-89.15%

Current Drawdown

ELMD:

-39.18%

BSX:

-0.13%

Fundamentals

Market Cap

ELMD:

$180.72M

BSX:

$155.14B

EPS

ELMD:

$0.75

BSX:

$1.37

PE Ratio

ELMD:

28.73

BSX:

76.54

PEG Ratio

ELMD:

0.00

BSX:

2.58

PS Ratio

ELMD:

2.94

BSX:

8.84

PB Ratio

ELMD:

3.76

BSX:

6.98

Total Revenue (TTM)

ELMD:

$61.44M

BSX:

$17.55B

Gross Profit (TTM)

ELMD:

$47.65M

BSX:

$11.79B

EBITDA (TTM)

ELMD:

$9.66M

BSX:

$4.09B

Returns By Period

In the year-to-date period, ELMD achieves a -27.07% return, which is significantly lower than BSX's 18.72% return. Over the past 10 years, ELMD has outperformed BSX with an annualized return of 25.14%, while BSX has yielded a comparatively lower 19.38% annualized return.


ELMD

YTD

-27.07%

1M

-4.94%

6M

-25.20%

1Y

26.32%

5Y*

9.57%

10Y*

25.14%

BSX

YTD

18.72%

1M

11.33%

6M

21.90%

1Y

42.24%

5Y*

25.01%

10Y*

19.38%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ELMD vs. BSX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELMD
The Risk-Adjusted Performance Rank of ELMD is 6969
Overall Rank
The Sharpe Ratio Rank of ELMD is 7171
Sharpe Ratio Rank
The Sortino Ratio Rank of ELMD is 6666
Sortino Ratio Rank
The Omega Ratio Rank of ELMD is 6666
Omega Ratio Rank
The Calmar Ratio Rank of ELMD is 7575
Calmar Ratio Rank
The Martin Ratio Rank of ELMD is 6969
Martin Ratio Rank

BSX
The Risk-Adjusted Performance Rank of BSX is 9494
Overall Rank
The Sharpe Ratio Rank of BSX is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of BSX is 9191
Sortino Ratio Rank
The Omega Ratio Rank of BSX is 9494
Omega Ratio Rank
The Calmar Ratio Rank of BSX is 9696
Calmar Ratio Rank
The Martin Ratio Rank of BSX is 9696
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ELMD vs. BSX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Electromed, Inc. (ELMD) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current ELMD Sharpe Ratio is 0.51, which is lower than the BSX Sharpe Ratio of 1.91. The chart below compares the historical Sharpe Ratios of ELMD and BSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

ELMD vs. BSX - Dividend Comparison

Neither ELMD nor BSX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ELMD vs. BSX - Drawdown Comparison

The maximum ELMD drawdown since its inception was -78.65%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for ELMD and BSX. For additional features, visit the drawdowns tool.


Loading data...

Volatility

ELMD vs. BSX - Volatility Comparison

Electromed, Inc. (ELMD) has a higher volatility of 20.46% compared to Boston Scientific Corporation (BSX) at 5.81%. This indicates that ELMD's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

ELMD vs. BSX - Financials Comparison

This section allows you to compare key financial metrics between Electromed, Inc. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20212022202320242025
15.68M
4.66B
(ELMD) Total Revenue
(BSX) Total Revenue
Values in USD except per share items

ELMD vs. BSX - Profitability Comparison

The chart below illustrates the profitability comparison between Electromed, Inc. and Boston Scientific Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%20212022202320242025
78.0%
68.8%
(ELMD) Gross Margin
(BSX) Gross Margin
ELMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Electromed, Inc. reported a gross profit of 12.23M and revenue of 15.68M. Therefore, the gross margin over that period was 78.0%.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a gross profit of 3.21B and revenue of 4.66B. Therefore, the gross margin over that period was 68.8%.

ELMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Electromed, Inc. reported an operating income of 2.14M and revenue of 15.68M, resulting in an operating margin of 13.6%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported an operating income of 921.00M and revenue of 4.66B, resulting in an operating margin of 19.8%.

ELMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Electromed, Inc. reported a net income of 1.89M and revenue of 15.68M, resulting in a net margin of 12.1%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a net income of 674.00M and revenue of 4.66B, resulting in a net margin of 14.5%.